Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphoma.

Blood Adv · 2026 · PMC12914426 · PMID 41686452

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

We also noted a nonsignificant trend toward greater peak and AUC interferon gamma (IFN-γ) levels in ibrutinib-exposed patients ( Figure 2 D).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.